N-[[1-[(2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]triazol-4-yl]methyl]-2-(3-oxobenzo[f]chromen-1-yl)acetamide

C28H26N6O7 — CID 102148745

IUPACN-[[1-[(2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]triazol-4-yl]methyl]-2-(3-oxobenzo[f]chromen-1-yl)acetamide
SMILESCc1cn([C@H]2C[C@H](n3cc(CNC(=O)Cc4cc(=O)oc5ccc6ccccc6c45)nn3)[C@@H](CO)O2)c(=O)[nH]c1=O
InChIInChI=1S/C28H26N6O7/c1-15-12-33(28(39)30-27(15)38)24-10-20(22(14-35)40-24)34-13-18(31-32-34)11-29-23(36)8-17-9-25(37)41-21-7-6-16-4-2-3-5-19(16)26(17)21/h2-7,9,12-13,20,22,24,35H,8,10-11,14H2,1H3,(H,29,36)(H,30,38,39)/t20-,22+,24+/m0/s1
InChIKeyIWDUMAHISDPYGK-BGWNEDDSSA-N
MW558.55 g/mol
LogP1.08
Rot. Bonds7

About N-[[1-[(2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]triazol-4-yl]methyl]-2-(3-oxobenzo[f]chromen-1-yl)acetamide

N-[[1-[(2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]triazol-4-yl]methyl]-2-(3-oxobenzo[f]chromen-1-yl)acetamide (PubChem CID 102148745) has the molecular formula C28H26N6O7 and a molecular weight of 558.55 g/mol. Its IUPAC name is N-[[1-[(2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]triazol-4-yl]methyl]-2-(3-oxobenzo[f]chromen-1-yl)acetamide.

Molecular Properties

Compound NameN-[[1-[(2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]triazol-4-yl]methyl]-2-(3-oxobenzo[f]chromen-1-yl)acetamide
PubChem CID102148745
Molecular FormulaC28H26N6O7
Molecular Weight558.55 g/mol
Exact Mass558.19
IUPAC NameN-[[1-[(2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]triazol-4-yl]methyl]-2-(3-oxobenzo[f]chromen-1-yl)acetamide
SMILESCc1cn([C@H]2C[C@H](n3cc(CNC(=O)Cc4cc(=O)oc5ccc6ccccc6c45)nn3)[C@@H](CO)O2)c(=O)[nH]c1=O
InChIInChI=1S/C28H26N6O7/c1-15-12-33(28(39)30-27(15)38)24-10-20(22(14-35)40-24)34-13-18(31-32-34)11-29-23(36)8-17-9-25(37)41-21-7-6-16-4-2-3-5-19(16)26(17)21/h2-7,9,12-13,20,22,24,35H,8,10-11,14H2,1H3,(H,29,36)(H,30,38,39)/t20-,22+,24+/m0/s1
InChIKeyIWDUMAHISDPYGK-BGWNEDDSSA-N
XLogP1.08
TPSA174.34 Ų
H-Bond Donors3
H-Bond Acceptors11
Rotatable Bonds7
Heavy Atoms41
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500558.55
LogP ≤ 51.08
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'cumarine', 'substructure': 'N/A'}, {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Analyze N-[[1-[(2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]triazol-4-yl]methyl]-2-(3-oxobenzo[f]chromen-1-yl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[[1-[(2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]triazol-4-yl]methyl]-2-(3-oxobenzo[f]chromen-1-yl)acetamide?
The IUPAC name of N-[[1-[(2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]triazol-4-yl]methyl]-2-(3-oxobenzo[f]chromen-1-yl)acetamide (CID 102148745) is N-[[1-[(2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]triazol-4-yl]methyl]-2-(3-oxobenzo[f]chromen-1-yl)acetamide.
What is the SMILES notation for N-[[1-[(2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]triazol-4-yl]methyl]-2-(3-oxobenzo[f]chromen-1-yl)acetamide?
The canonical SMILES for N-[[1-[(2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]triazol-4-yl]methyl]-2-(3-oxobenzo[f]chromen-1-yl)acetamide is Cc1cn([C@H]2C[C@H](n3cc(CNC(=O)Cc4cc(=O)oc5ccc6ccccc6c45)nn3)[C@@H](CO)O2)c(=O)[nH]c1=O.
What is the InChIKey of N-[[1-[(2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]triazol-4-yl]methyl]-2-(3-oxobenzo[f]chromen-1-yl)acetamide?
The InChIKey is IWDUMAHISDPYGK-BGWNEDDSSA-N. The full InChI is InChI=1S/C28H26N6O7/c1-15-12-33(28(39)30-27(15)38)24-10-20(22(14-35)40-24)34-13-18(31-32-34)11-29-23(36)8-17-9-25(37)41-21-7-6-16-4-2-3-5-19(16)26(17)21/h2-7,9,12-13,20,22,24,35H,8,10-11,14H2,1H3,(H,29,36)(H,30,38,39)/t20-,22+,24+/m0/s1.
What are the key properties of N-[[1-[(2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]triazol-4-yl]methyl]-2-(3-oxobenzo[f]chromen-1-yl)acetamide?
N-[[1-[(2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]triazol-4-yl]methyl]-2-(3-oxobenzo[f]chromen-1-yl)acetamide has a molecular weight of 558.55 g/mol, XLogP of 1.08, 7 rotatable bonds, 3 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[1-[(2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]triazol-4-yl]methyl]-2-(3-oxobenzo[f]chromen-1-yl)acetamide is sourced from PubChem (CID 102148745), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).